API reference
DOXORUBICIN HCl
- CAS number
- 25316-40-9
- Molecular formula
- C27H30ClNO11
- Molecular weight
- 580 g/mol
About this molecule
Doxorubicin hydrochloride (liposomal) is an antineoplastic prescription medicine approved by the U.S. Food and Drug Administration (FDA) for the treatment of certain types of cancer, including ovarian cancer, multiple myeloma, and AIDS-related Kaposi sarcoma. Kaposi sarcoma is caused by infection with human herpesvirus-8 (HHV-8). HHV-8 infection can be an opportunistic infection (OI) of HIV.
Source: Drug Database, Clinicalinfo.hiv.gov, via PubChem.
Identifiers
- IUPAC name
- (7S,9S)-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione;hydrochloride
- InChIKey
- MWWSFMDVAYGXBV-RUELKSSGSA-N
- SMILES
- C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N)O.Cl
- PubChem CID
- 443939
Also known as
Doxorubicin Hydrochloride · Doxorubicin HCl · Adriacin · ADRIAMYCIN HYDROCHLORIDE · Adriamycin PFS · Adriamycin RDF · Adriablastina cs · ADRIAMYCIN, HYDROCHLORIDE
Chemical data on this page is drawn from PubChem (National Library of Medicine) and is provided for identification only. Hanpars does not hold stock of every substance listed; availability, grade, documentation and regulatory status are confirmed per enquiry.
Tell us the grade, the quantity and the market.
Send the molecule or ingredient, the specification and the destination. We reply from Tehran with the questions, the documents and the next step.